{{Rsnum
|rsid=7747724
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Chromosome=6
|Orientation=plus
|Gene=CDKAL1
|position=20751084
|Gene_s=CDKAL1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 21.2 | 48.7 | 30.1
| HCB | 4.4 | 34.3 | 61.3
| JPT | 7.1 | 31.9 | 61.1
| YRI | 20.4 | 44.9 | 34.7
| ASW | 21.1 | 56.1 | 22.8
| CHB | 4.4 | 34.3 | 61.3
| CHD | 0.9 | 32.1 | 67.0
| GIH | 7.9 | 43.6 | 48.5
| LWK | 15.5 | 54.5 | 30.0
| MEX | 15.5 | 41.4 | 43.1
| MKK | 16.0 | 50.6 | 33.3
| TSI | 26.5 | 49.0 | 24.5
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=24163127
  |Trait=Bladder cancer
  |Title=Genome-wide association study identifies multiple loci associated with bladder cancer risk.
  |RiskAllele=
  |Pval=1E-6
  |OR=1.11
  |ORtxt=[1.06-1.16]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}